VITREX MEDICAL A/S: Financial statements 2025
CVR: 14728732
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
VITREX MEDICAL A/S (CVR 14728732) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 34,669,165 and a net result of DKK 6,179,533 compared with DKK 1,819,121 the year before. That is an increase of 19.8% compared with the year before. Equity in the 2025 report amounted to DKK 42,246,689. The solvency ratio was 66.1%. The company had 59 employees in the financial year.
- Gross Profit
- DKK 34,669,165
- Profit/Loss
- DKK 6,179,533
- Equity
- DKK 42,246,689
- Total Assets
- DKK 63,892,391
- Employees
- 59
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 34.7M | 6.2M | 42.2M | 59 |
| 2024 | - | 28.9M | 1.8M | 36.1M | 66 |
| 2023 | - | 28.1M | 1.2M | 34.2M | 68 |
| 2022 | - | 26.6M | 4.1M | 33M | 73 |
| 2021 | - | 28.6M | 5.5M | 32M | 68 |
Official annual report
How creditworthy is VITREX MEDICAL A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
VITREX MEDICAL A/S has won the tender "Genudbud af sutur" issued by Region Hovedstaden worth 50,641,955 DKK.
VITREX MEDICAL A/S has published its annual report for 2024. Gross profit came to DKK 28,936,706, and the net result was DKK 1,819,121.
About VITREX MEDICAL A/S
VITREX MEDICAL A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 1990. The company is registered under the industry Fremstilling og bearbejdning af andet glas, herunder teknisk glas. The company was previously named MODULOHM A/S and A/S PSE NR. 4106. The management consists of Anders Folkmar Pedersen. The board consists of Michal Staron (chair), Marcin Sieczek and Vagn Andersen. The company is owned by CHIRANA T.Injecta, a. s.. The company has 60 employees (2026). In 2025, the company reported a gross profit of DKK 34,669,165 and a net result of DKK 6,179,533 compared with DKK 1,819,121 the year before. Equity in the 2025 report amounted to DKK 42,246,689.
